- Investing Ideas
- /
- U.S. High Growth Tech and AI Stocks
U.S. High Growth Tech and AI Stocks
Results
240
Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.
240 companies
Alnylam Pharmaceuticals
Market Cap: US$30.2b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$238.74
7D
-1.7%
1Y
62.8%
AVITA Medical
Market Cap: US$219.3m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$8.37
7D
-4.5%
1Y
-50.8%
Travere Therapeutics
Market Cap: US$1.6b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$18.13
7D
-8.0%
1Y
133.9%
Alkami Technology
Market Cap: US$2.4b
Provides cloud-based digital banking solutions in the United States.
ALKT
US$23.76
7D
-17.6%
1Y
0.4%
TG Therapeutics
Market Cap: US$5.7b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$37.55
7D
5.4%
1Y
137.1%
Lumentum Holdings
Market Cap: US$4.0b
Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LITE
US$62.05
7D
-4.7%
1Y
32.4%
TKO Group Holdings
Market Cap: US$24.3b
Operates as a sports and entertainment company.
TKO
US$145.15
7D
-1.1%
1Y
78.6%
Clene
Market Cap: US$36.6m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$4.54
7D
6.6%
1Y
-48.9%
Applied Optoelectronics
Market Cap: US$702.6m
Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.
AAOI
US$15.07
7D
-16.9%
1Y
5.7%
Blueprint Medicines
Market Cap: US$5.5b
A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
BPMC
US$87.76
7D
-1.8%
1Y
-2.2%
Legend Biotech
Market Cap: US$6.2b
A clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally.
LEGN
US$37.19
7D
9.4%
1Y
-42.9%
Bitdeer Technologies Group
Market Cap: US$1.9b
Operates as a technology company for blockchain and computing.
BTDR
US$10.57
7D
-7.1%
1Y
68.0%
Palantir Technologies
Market Cap: US$179.1b
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
PLTR
US$78.05
7D
-7.5%
1Y
216.0%
Alvotech
Market Cap: US$3.2b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$10.81
7D
0%
1Y
-29.4%
Silence Therapeutics
Market Cap: US$212.5m
A biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.
SLN
US$4.22
7D
-5.8%
1Y
-83.7%
SideChannel
Market Cap: US$8.2m
SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.
SDCH
US$0.038
7D
-11.8%
1Y
-37.7%
Sarepta Therapeutics
Market Cap: US$9.7b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
SRPT
US$100.71
7D
-2.1%
1Y
-17.5%
Workday
Market Cap: US$64.6b
Provides enterprise cloud applications in the United States and internationally.
WDAY
US$242.93
7D
-4.2%
1Y
-10.4%
TruGolf Holdings
Market Cap: US$8.2m
Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.
TRUG
US$0.37
7D
-0.4%
1Y
-74.6%
Similarweb
Market Cap: US$745.4m
Provides cloud-based digital intelligence solutions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.
SMWB
US$8.82
7D
-4.4%
1Y
-2.0%
Abeona Therapeutics
Market Cap: US$219.1m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.46
7D
7.7%
1Y
-33.3%
Checkpoint Therapeutics
Market Cap: US$194.4m
A clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.
CKPT
US$4.00
7D
52.1%
1Y
100.0%
Neonode
Market Cap: US$134.8m
Develops optical sensing solutions for contactless touch, touch, and gesture sensing in the United States, Japan, South Korea, Germany, Switzerland, France, Sweden, China, and internationally.
NEON
US$7.73
7D
-5.2%
1Y
503.9%
DigitalOcean Holdings
Market Cap: US$3.4b
Through its subsidiaries, operates a cloud computing platform in North America, Europe, Asia, and internationally.
DOCN
US$36.27
7D
-10.3%
1Y
-10.3%
MeiraGTx Holdings
Market Cap: US$476.0m
A clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases.
MGTX
US$6.10
7D
-8.6%
1Y
0.5%
Exelixis
Market Cap: US$11.0b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$36.93
7D
-3.6%
1Y
62.8%
Gauzy
Market Cap: US$156.3m
An integrated light and vision control company, develops, manufactures, and supplies liquid crystal controllers and films in Israel, the United States, Europe, France, Asia, and internationally.
GAUZ
US$10.64
7D
16.7%
1Y
n/a
TeraWulf
Market Cap: US$1.2b
Operates as a digital asset technology company in the United States.
WULF
US$3.17
7D
-9.1%
1Y
79.8%
Zscaler
Market Cap: US$30.1b
Operates as a cloud security company worldwide.
ZS
US$199.36
7D
2.9%
1Y
-0.9%
CarGurus
Market Cap: US$3.2b
Operates an online automotive platform for buying and selling vehicles in the United States and internationally.
CARG
US$31.80
7D
-0.2%
1Y
38.3%
Spotify Technology
Market Cap: US$100.2b
Provides audio streaming subscription services worldwide.
SPOT
US$508.44
7D
-13.0%
1Y
97.0%
Vanda Pharmaceuticals
Market Cap: US$274.7m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.98
7D
3.5%
1Y
28.4%
Soleno Therapeutics
Market Cap: US$2.0b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$44.78
7D
0.8%
1Y
2.1%
UroGen Pharma
Market Cap: US$457.3m
A biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$10.82
7D
12.7%
1Y
-38.6%
ACADIA Pharmaceuticals
Market Cap: US$2.9b
A biopharmaceutical company, focuses on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$17.19
7D
-5.9%
1Y
-14.0%
Aldeyra Therapeutics
Market Cap: US$395.3m
A biotechnology company, develops and commercializes medicines for immune-mediated diseases.
ALDX
US$6.92
7D
12.2%
1Y
130.3%